COVID-19 Updates
Feature
Many young kids with COVID may show no symptoms
The relationship between symptoms and viral load also differed between adults and young children in a new study.
News
FDA authorizes updated COVID boosters to target newest variants
The agency cited data to support the safety and efficacy of this next generation of mRNA vaccines targeted toward variants of concern.
Feature
How do you live with COVID? One doctor’s personal experience
Early in 2020, Anne Peters, MD, caught COVID-19. The author of Medscape’s “Peters on Diabetes” column was sick in March 2020 before state-mandated...
From the Journals
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
Patients with immune-mediated inflammatory diseases have weaker vaccine-induced immunity to COVID but are able to build a humoral immune response...
From the Journals
Paxlovid reduces risk of COVID death by 79% in older adults
“Treatment with Paxlovid significantly reduces the risk of hospitalization and death from COVID-19.”
From the Journals
Hospitalized COVID-19 patients with GI symptoms have worse outcomes
Patients with GI symptoms were more likely to have higher Charlson Comorbidity Index scores and be 50 years and older.
Guidance for Practicing Primary Care
Preparing for back to school amid monkeypox outbreak and ever-changing COVID landscape
The best defense that we currently have against COVID is the vaccine.
News from the FDA/CDC
COVID to blame as U.S. life expectancy falls
The overall drop took national life expectancy from 78.8 years in 2019 to 77 years in 2020.
From the Journals
Metformin fails as early COVID-19 treatment but shows potential
Metformin may merit further investigation for adults who are overweight or obese.
From the Journals
Regular physical activity may fight infection, illness from COVID: Study
Regular physical activity may help lower the risk of COVID-19 infection and its severity.
Highlights
Guidelines on GLP1RAs and continuous glucose monitors are among biggest news in diabetes
Some GLP1RAs have shown impressive weight reduction properties and cardiovascular benefits, says an endocrinologist.